Consolidated Statements of Operations and Comprehensive Earnings and Loss - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2014
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 64,871	$ 77,424	$ 77,564
Less provision for bad debts of Healthcare Facilities Segment	1,438	3,678	3,795
Net Revenues	63,433	73,746	73,769
Costs and expenses:
Cost of goods sold	20,404	21,042	22,110
Salaries, wages and benefits	30,783	33,620	32,771
Provision for bad debts of Specialty Pharmacy Segment	630	363	255
Supplies	3,326	4,366	4,236
Purchased services	3,248	3,616	3,288
Other operating expenses	8,031	6,893	9,142
Rents and leases expense	791	818	877
Impairment of property, plant and equipment	858	0	0
Insurance settlement	0	(1,000)	0
Depreciation and amortization	1,878	1,837	2,322
Electronic Health Records incentive payments	7	(29)	(2,274)
Operating profit (loss)	(6,523)	2,220	1,042
Other income (expense):
Interest expense	(843)	(861)	(944)
Gain (loss) on sale of assets	10	21	(41)
Earnings (Loss) from continuing operations before income taxes	(7,356)	1,380	57
Income tax (benefit) expense	4,558	893	541
Earnings (loss) from continuing operations	(11,914)	487	(484)
Loss from discontinued operations, net of income taxes	(2,169)	(242)	(61)
Net earnings (loss)	(14,083)	245	(545)
Other comprehensive income (loss)	(46)	(40)	72
Comprehensive income (loss)	$ (14,129)	$ 205	$ (473)
Continuing operations:
Basic	$ (1.26)	$ 0.05	$ (0.05)
Diluted	(1.26)	0.05	(0.05)
Discontinued operations:
Basic	(0.23)	(0.02)	(0.01)
Diluted	(0.23)	(0.02)	(0.01)
Net earnings (loss):
Basic	(1.49)	0.03	(0.06)
Diluted	$ (1.49)	$ 0.03	$ (0.06)
Weighted-average common shares outstanding:
Basic	9,443	9,443	9,443
Diluted	9,443	9,496	9,456